These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6805158

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A comparison of dual skin test with mycobacterial antigens and tuberculin skin test alone in estimating prevalence of Mycobacterium tuberculosis infection from population surveys.
    Bierrenbach AL, Floyd S, Cunha SC, Dourado I, Barreto ML, Pereira SM, Hijjar MA, Rodrigues LC.
    Int J Tuberc Lung Dis; 2003 Apr; 7(4):312-9. PubMed ID: 12729335
    [Abstract] [Full Text] [Related]

  • 23. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE, Gavier-Widen D, Hewinson RG, Hogarth PJ.
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [Abstract] [Full Text] [Related]

  • 24. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E, Nicolle F, Clark S, Majlessi L, Boudou F, Martino A, Castello-Branco L, Leclerc C, Lewis DJ, Marsh PD, Gicquel B, Winter N.
    Vaccine; 2009 Jan 01; 27(1):28-37. PubMed ID: 18977269
    [Abstract] [Full Text] [Related]

  • 25. Endocellular antigens of Romanian BCG daughter-strain.
    Stavri D, Movileanu D, Stavri H.
    Arch Roum Pathol Exp Microbiol; 1976 Jan 01; 35(1-2):153-8. PubMed ID: 795398
    [No Abstract] [Full Text] [Related]

  • 26. [Attempts at isolation and characterization of immunogenically active fractions of Mycobacterium tuberculosis and Mycobacterium bovis (BCG). 3. Immunochemical properties of the fractions].
    Klose F, Schallehn G.
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep 01; 131(3):201-18. PubMed ID: 4231179
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis.
    Feng CG, Palendira U, Demangel C, Spratt JM, Malin AS, Britton WJ.
    Infect Immun; 2001 Jun 01; 69(6):4174-6. PubMed ID: 11349095
    [Abstract] [Full Text] [Related]

  • 29. [Antigenic analysis of the structural components of the surface of BCG cells].
    Shimono T, Kotani S, Kato K, Hirachi Y.
    Nihon Saikingaku Zasshi; 1975 Jan 01; 30(1):90. PubMed ID: 765574
    [No Abstract] [Full Text] [Related]

  • 30. Tuberculin hypersensitivity following BCG vaccination in Brisbane school children.
    Abrahams EW.
    Tubercle; 1979 Jun 01; 60(2):109-13. PubMed ID: 112744
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M, Howard C, Villarreal-Ramos B, Mead E, Vordermeier M, Hope J.
    Tuberculosis (Edinb); 2008 Jul 01; 88(4):324-34. PubMed ID: 18329343
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The use of two-dimensional immunoelectrophoresis for the characterization of antigens of BCG substrains.
    Lipińska R, Rzucidło L.
    Acta Microbiol Pol; 1978 Jul 01; 27(1):35-40. PubMed ID: 76422
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.